GSK Expects Vaccine Approval in First Half of 2021

Jul.31 — The Trump administration will provide as much as $2.1 billion to Covid-19 vaccine partners Sanofi and GlaxoSmithKline Plc, the biggest U.S. investment yet in fast-tracking shots and snapping up supplies. Roger Connor, GSK global vaccines president, appears on "Bloomberg Markets."

Watch the video at Bloomberg – Corona Outbreak

Related Articles

Back to top button